MCKESSON CORPORATION : “Best of ASH” Features Two Studies with Contributions …4-traders (press release)… in Combination with Rituximab and/or Bendamustine in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) – authored by …
Novartis begins more Phase III biosimilar studies of Amgen drugsPharma TimesAmeet Mallik, head of Sandoz biopharmaceuticals, added that a late-stage trials for a biosimilar of Roche's Rituxan (rituximab) is ongoing and the pipeline, consists of eig…
Making Inroads in Treating RA, a Clinical Context ReportMedPage TodayWALSH: And that sort of thing would help you if you were going to try using other agents, like the IL-6 inhibitors or rituximab. PUTTERMAN: If we would know in advance, as an example,…
Novartis moves ahead with copies of Amgen drugsEconomic TimesSandoz, which has 8-10 molecules in its biosimilar pipeline, has been trying to come up with a copy of Roche's antibody drug rituximab. It has already developed its own versions of growth…
Gas on Autoimmune Diseases Hit by A Genetic AcceleratorMedIndiaThe therapies currently used are based on cortisone, anti-malarial drugs and immunosuppressants (azathioprine, mycophenolate, cyclophosphamide) and biologic drugs (rituximab, Belimumab). Bu…
Rituximab Ineffective as Lupus Nephritis Add-On TherapyRenal and Urology NewsAdding rituximab to mycophenolate mofetil and corticosteroids does not improve outcomes in patients with lupus nephritis (LN), according to a study. As part of the Lupus Nephr…
INTERVIEW: New EU Drug Chief Says Biotech Copy Guidance ComingCapital.gr (press release)VX) blockbuster cancer drug rituximab loses patent protection. In contrast to traditional generics–copies of chemically synthesized drugs–biotech generics attempt…
Nodal Marginal Zone Lymphoma: What Do We Really Know?Cancer NetworkFor example, the RESORT trial,[2] which addressed the question of maintenance rituximab vs retreatment rituximab, was designed statistically to test the question in patients with follic…
Nodal Marginal Zone Lymphoma: Impersonalized MedicineCancer Network[12] More recently, impressive response rates coupled with manageable toxicity have created significant interest in the use of bendamustine with rituximab for indolent NHLs; however, th…
Drug shortages raising supply chain risk, says FDASecuring Pharma… including unapproved versions of AstraZeneca's breast cancer drug Faslodex (fulvestrant), Amgen's white blood cell stimulator Neupogen (filgrastim), and Roche's cancer dru…